BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25352635)

  • 1. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z; Jiang X; Pansuria M; Fang P; Mai J; Mallilankaraman K; Gandhirajan RK; Eguchi S; Scalia R; Madesh M; Yang X; Wang H
    Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation.
    Jiang X; Yang F; Tan H; Liao D; Bryan RM; Randhawa JK; Rumbaut RE; Durante W; Schafer AI; Yang X; Wang H
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2515-21. PubMed ID: 16210565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide.
    Cheng Z; Shen X; Jiang X; Shan H; Cimini M; Fang P; Ji Y; Park JY; Drosatos K; Yang X; Kevil CG; Kishore R; Wang H
    Redox Biol; 2018 Jun; 16():215-225. PubMed ID: 29524844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling.
    Yan TT; Li Q; Zhang XH; Wu WK; Sun J; Li L; Zhang Q; Tan HM
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1071-7. PubMed ID: 20698860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells.
    Srinivasan S; Hatley ME; Bolick DT; Palmer LA; Edelstein D; Brownlee M; Hedrick CC
    Diabetologia; 2004 Oct; 47(10):1727-34. PubMed ID: 15490108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice.
    Dayal S; Arning E; Bottiglieri T; Böger RH; Sigmund CD; Faraci FM; Lentz SR
    Stroke; 2004 Aug; 35(8):1957-62. PubMed ID: 15178827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects and related mechanism of 5-aza-2'-deoxycytidine on endothelial function in rats with hyperhomocysteinemia].
    Gao SL; Li L; Zhai XJ; Guo RW; Gao SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):700-6. PubMed ID: 27545130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries.
    Looft-Wilson RC; Ashley BS; Billig JE; Wolfert MR; Ambrecht LA; Bearden SE
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R59-66. PubMed ID: 18448615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca
    Ji XW; Lyu HJ; Zhou GH; Wu B; Zhu YY; Wu TH; Zhang F; Jin SN; Cho KW; Wen JF
    Phytomedicine; 2021 Jan; 81():153410. PubMed ID: 33285470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.
    Fang P; Zhang D; Cheng Z; Yan C; Jiang X; Kruger WD; Meng S; Arning E; Bottiglieri T; Choi ET; Han Y; Yang XF; Wang H
    Diabetes; 2014 Dec; 63(12):4275-90. PubMed ID: 25008174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Tongxinluo superfine on experimental anginal model (contraction of collaterals) in rat with endothelial dysfunction].
    Han YL; Cheng C; Tan HM; Wu WK; Wu YL; Sun HL; Sun J; Chen JL
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2404-8, 2426. PubMed ID: 18257270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytoestrogen α-zearalanol improves vascular function in ovariectomized hyperhomocysteinemic rats.
    Zhen PP; Duan JH; Zhao Q; Hou DD; Wang HX; Hong N; Zhen HX; Wang W
    Atherosclerosis; 2011 Apr; 215(2):309-15. PubMed ID: 21292265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice.
    Cheng Z; Jiang X; Kruger WD; Praticò D; Gupta S; Mallilankaraman K; Madesh M; Schafer AI; Durante W; Yang X; Wang H
    Blood; 2011 Aug; 118(7):1998-2006. PubMed ID: 21653942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia inhibits post-injury reendothelialization in mice.
    Tan H; Jiang X; Yang F; Li Z; Liao D; Trial J; Magera MJ; Durante W; Yang X; Wang H
    Cardiovasc Res; 2006 Jan; 69(1):253-62. PubMed ID: 16226235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
    Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
    Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells.
    Sen U; Tyagi N; Kumar M; Moshal KS; Rodriguez WE; Tyagi SC
    Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1779-87. PubMed ID: 17855772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
    Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
    Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. μ-Calpain as a Novel Target for Impairment of Nitric Oxide-Mediated Vascular Relaxation in Diabetes: A Mini Review.
    Kishore R; Benedict C; Cheng Z
    J Mol Genet Med; 2015 May; 9(2):. PubMed ID: 26120352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.